• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.遗传性血管性水肿:血浆激肽及血管通透性增强活性的特征
Clin Exp Immunol. 1994 Jan;95(1):22-8. doi: 10.1111/j.1365-2249.1994.tb06009.x.
2
Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.补体第二成分(C2)和纤溶酶在遗传性血管性水肿(H.A.N.E.)血浆激肽释放中的作用。
Trans Assoc Am Physicians. 1977;90:174-83.
3
Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.血浆蛋白酶对补体第二成分的裂解:对遗传性C1抑制物缺乏症的影响。
Immunology. 1985 Nov;56(3):561-70.
4
Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin.遗传性血管性水肿血浆中的激肽形成:反对激肽源自C2的证据及支持缓激肽“自发”形成的证据
J Allergy Clin Immunol. 1983 Jul;72(1):54-60. doi: 10.1016/0091-6749(83)90052-0.
5
Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.遗传性血管性水肿(H.A.N.E.)血浆中的激肽生成
Adv Exp Med Biol. 1983;156:183-91.
6
Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria.遗传性血管性水肿(HANE)和荨麻疹中C1-抑制物、凝血、纤维蛋白溶解和激肽系统之间的相互作用。
Arch Dermatol Res. 1984;276(6):375-80. doi: 10.1007/BF00413358.
7
The pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学
Clin Immunol. 2005 Jan;114(1):3-9. doi: 10.1016/j.clim.2004.05.007.
8
Activation of the coagulation cascade in C1-inhibitor deficiencies.C1抑制剂缺乏时凝血级联反应的激活。
Blood. 1997 May 1;89(9):3213-8.
9
C1-inhibitor--biochemical properties and clinical applications.C1 抑制剂——生化特性与临床应用
Crit Rev Immunol. 1985;5(4):317-30.
10
[Biological investigation of kinin-mediated angioedema].
Ann Dermatol Venereol. 2015 Mar;142(3):163-9. doi: 10.1016/j.annder.2015.01.018. Epub 2015 Feb 13.

引用本文的文献

1
The international HAE guideline under real-life conditions: From possibilities to limits in daily life - current real-world data of 8 German angioedema centers.现实生活条件下的国际遗传性血管性水肿指南:从日常生活中的可能性到局限性——德国8个血管性水肿中心的当前真实世界数据
Allergol Select. 2024 Nov 14;8:346-357. doi: 10.5414/ALX02530E. eCollection 2024.
2
A novel murine in vivo model for acute hereditary angioedema attacks.一种用于急性遗传性血管性水肿发作的新型小鼠体内模型。
Sci Rep. 2021 Aug 5;11(1):15924. doi: 10.1038/s41598-021-95125-0.
3
The Search for Biomarkers in Hereditary Angioedema.遗传性血管性水肿生物标志物的研究
Front Med (Lausanne). 2017 Nov 22;4:206. doi: 10.3389/fmed.2017.00206. eCollection 2017.
4
The Story of Angioedema: from Quincke to Bradykinin.血管性水肿的故事:从昆克到缓激肽。
Clin Rev Allergy Immunol. 2016 Oct;51(2):121-39. doi: 10.1007/s12016-016-8553-8.
5
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.补体、激肽与遗传性血管性水肿:C1 抑制剂缺乏时血浆不稳定的机制
Clin Rev Allergy Immunol. 2016 Oct;51(2):207-15. doi: 10.1007/s12016-016-8555-6.
6
"Nuts and Bolts" of Laboratory Evaluation of Angioedema.血管性水肿实验室评估的“基本要点”
Clin Rev Allergy Immunol. 2016 Oct;51(2):140-51. doi: 10.1007/s12016-016-8539-6.
7
Pathophysiology of Hereditary Angioedema.遗传性血管性水肿的病理生理学
Pediatr Allergy Immunol Pulmonol. 2014 Dec 1;27(4):159-163. doi: 10.1089/ped.2014.0425.
8
Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema.利妥昔单抗治疗1例低度B细胞淋巴增殖性疾病合并获得性血管性水肿患者。
J Asthma Allergy. 2014 Dec 2;7:165-7. doi: 10.2147/JAA.S68548. eCollection 2014.
9
Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies.遗传性血管性水肿致 C1 酯酶抑制剂缺乏症:基于文献的分析和预防治疗策略的临床评论。
World Allergy Organ J. 2011 Feb;4(2 Suppl):S9-S21. doi: 10.1097/WOX.0b013e31821359a2.
10
The pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学。
World Allergy Organ J. 2010 Sep;3(9 Suppl):S25-8. doi: 10.1097/WOX.0b013e3181f3f21c.

本文引用的文献

1
Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).菲茨杰拉德特质:凝血、纤维蛋白溶解、激肽生成的表面介导反应以及稀释血浆增强血管通透性(PF/Dil)的 hitherto 尚未被识别的因子、菲茨杰拉德因子的缺乏。
J Clin Invest. 1975 May;55(5):1082-9. doi: 10.1172/JCI108009.
2
COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.补体作为炎症介质。纯化的人C1酯酶对血管通透性的增强作用。
J Exp Med. 1963 Nov 1;118(5):681-98. doi: 10.1084/jem.118.5.681.
3
A permeability factor released from guinea-pig serum by antigen-antibody precipitates.一种由抗原 - 抗体沉淀物从豚鼠血清中释放出的通透因子。
Br J Exp Pathol. 1960 Aug;41(4):335-44.
4
Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).遗传性血管性水肿(HAE)中的补体、凝血和纤维蛋白溶解参数
Clin Exp Immunol. 1982 Sep;49(3):618-22.
5
Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.遗传性血管性水肿患者诱导水疱液中活性激肽释放酶的检测
J Exp Med. 1980 Sep 1;152(3):742-7. doi: 10.1084/jem.152.3.742.
6
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.遗传性血管性水肿中的前激肽释放酶激活和高分子量激肽原消耗
N Engl J Med. 1983 May 5;308(18):1050-3. doi: 10.1056/NEJM198305053081802.
7
Human C1 inhibitor: improved isolation and preliminary structural characterization.人C1抑制剂:改进的分离方法及初步结构表征
Biochemistry. 1983 Oct 11;22(21):5001-7. doi: 10.1021/bi00290a019.
8
Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.用亲和层析法从科恩I组分中纯化补体第一成分的亚组分Clq、Cl(-)r和Cl(-)s。
Prep Biochem. 1980;10(3):269-96. doi: 10.1080/10826068009412829.
9
Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.遗传性血管性水肿(H.A.N.E.)血浆中的激肽生成
Adv Exp Med Biol. 1983;156:183-91.
10
Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin.遗传性血管性水肿血浆中的激肽形成:反对激肽源自C2的证据及支持缓激肽“自发”形成的证据
J Allergy Clin Immunol. 1983 Jul;72(1):54-60. doi: 10.1016/0091-6749(83)90052-0.

遗传性血管性水肿:血浆激肽及血管通透性增强活性的特征

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

作者信息

Shoemaker L R, Schurman S J, Donaldson V H, Davis A E

机构信息

Division of Nephrology, Children's Hospital Research Foundation, Cincinnati, OH 45229.

出版信息

Clin Exp Immunol. 1994 Jan;95(1):22-8. doi: 10.1111/j.1365-2249.1994.tb06009.x.

DOI:10.1111/j.1365-2249.1994.tb06009.x
PMID:8287604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1534616/
Abstract

The mediator(s) responsible for localized enhanced vascular permeability that characterizes an exacerbation of hereditary angioneurotic oedema (HAE) is thought to be a product of either contact or complement system activation. In contrast to normal individuals, plasma from these patients generates both kinin and vascular permeability-enhancing activity following incubation at 37 degrees C. Depletion of C1 inhibitor in both normal and C2-deficient plasma, but not in contact factor-deficient plasmas, resulted in generation of these activities. The kinin activity from incubated HAE plasma was susceptible to kininase inactivation and was blocked by a Bk2 receptor antagonist. Furthermore, this activity was isolated from HAE plasma; amino acid sequence analysis proved it to be bradykinin. Similarly, the vasopermeability-enhancing activity from ethanol-fractionated or boiled HAE plasma, collected during either attack or remission, co-eluted with bradykinin on reverse-phase high performance liquid chromatography (HPLC). These studies conclusively demonstrate that bradykinin is the major kinin and mediator of enhanced vascular permeability generated during incubation of HAE plasma. The role of other bioactive products, such as the C2 kinin, at local sites of oedema formation remains to be further defined.

摘要

遗传性血管性水肿(HAE)发作时具有局部血管通透性增强的特征,其相关介质被认为是接触系统或补体系统激活的产物。与正常人不同,这些患者的血浆在37℃孵育后会产生激肽和血管通透性增强活性。在正常血浆和C2缺陷血浆中消耗C1抑制剂可产生这些活性,但在接触因子缺陷血浆中则不会。孵育后的HAE血浆中的激肽活性易被激肽酶灭活,并被Bk2受体拮抗剂阻断。此外,该活性从HAE血浆中分离出来;氨基酸序列分析证明其为缓激肽。同样,在发作期或缓解期收集的经乙醇分级分离或煮沸的HAE血浆中的血管通透性增强活性,在反相高效液相色谱(HPLC)上与缓激肽共洗脱。这些研究确凿地证明,缓激肽是HAE血浆孵育过程中产生的主要激肽和血管通透性增强的介质。其他生物活性产物,如C2激肽,在水肿形成局部部位的作用仍有待进一步明确。